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Background: Microbiological diagnosis of sepsis relies primarily on blood culture data. This study compares four
diagnostic methods, i.e. those developed by us: nested, multiplex, qPCR (qPCR) and FISH with commercial methods:
SeptiFast (Roche) (SF) and BacT/ALERT® 3D blood culture system (bioMérieux). Blood samples were derived from
adult patients with clinical symptoms of sepsis, according to SIRS criteria, hospitalized in the Intensive Care Unit.
Results: Using qPCR, FISH, SF, and culture, microbial presence was found in 71.8%, 29.6%, 25.3%, and 36.6% of
samples, respectively. It was demonstrated that qPCR was significantly more likely to detect microorganisms than the
remaining methods; qPCR confirmed the results obtained with the SF kit in all cases wherein bacteria were detected
with simultaneous confirmation of Gram-typing. All data collected through the FISH method were corroborated by
qPCR.
Conclusions: The qPCR and FISH methods described in this study may constitute alternatives to blood culture and to
the few existing commercial molecular assays since they enable the detection of the majority of microbial species, and
the qPCR method allows their identification in a higher number of samples than the SF test. FISH made it possible to
show the presence of microbes in a blood sample even before its culture.
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Detecting the presence of microorganisms in the patient’s
blood is crucial to validate the diagnosis of sepsis. Until
now, the so-called diagnostic “gold standard” has been
constituted by blood cultures carried out on special,
universal growth media, preferably in automated cell
culture systems. The advantages of such methods are
their simplicity and relatively low costs of testing. Their
weakness is that they are time-consuming, taking up to
5 days (until the test results are issued), and have low
sensitivity, which causes only 15–20% of the culture to
obtain microbial growth. Detecting microbes in blood is* Correspondence: tomasz.gosiewski@uj.edu.pl
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unless otherwise stated.very difficult on account of their relatively small number,
additionally limited by previously applied antibiotic
treatment. [1,2]. Other, alternative, methods of detec-
tion of microbes in blood are being investigated [3-5].
These could reduce laboratory diagnosis time and pro-
vide greater sensitivity. An alternative is delivered by
molecular biology, which enables precise and rapid
detection of microbial genetic markers. Methods based on
PCR techniques come to the forefront. Unfortunately,
identification of microbes directly in blood encounters
numerous obstacles associated with their very small num-
ber in the sample, the presence of inhibitors disrupting
DNA amplification and the need to obtain nucleic acid
isolates of very good quality [6,7]. The mentioned diffi-
culties were the reason why, so far, there have been very
few commercially available diagnostic kits for molecularral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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(Molzym), or VYOO (SIRS-Lab) [8]. As an alternative to
nucleic acid amplification methods, FISH (Fluorescent In
Situ Hybridization) could be employed. Up to now, it has
been applied only with blood samples following culture,
which entails the necessity to wait for multiplication
of microorganisms [9,10]. In the literature, there are
reports on the use of a method based on the detection
of microbial proteins which allows to detect the species,
i.e. MALDI-TOF MS (matrix-assisted laser desorption/
ionization-time-of-flight mass spectrometry) and its com-
mercial counterpart, Sepsityper (Bruker Daltonics), which,
however, requires prior culture of the microorganism [11].
In blood infection treatment, the most important and
most difficult issue determining the effectiveness of
therapy and, consequently, the cost and duration of
hospitalization, is the diagnosis of causes of infection.
Rapid and modern diagnosis of sepsis requires application
of methods that enable the detection of microorganisms
directly from the patient’s blood sample within a few
hours, which will increase the chances of the patient’s
survival [12].
This study presents the results of laboratory tests on
comparison of the efficacy of four methods for detecting
the presence of microorganisms in the blood of adult
patients with clinical symptoms of sepsis according to SIRS
(systemic inflammatory response syndrome) criteria, i.e.:
SeptiFast (Roche) (SF), nested, multiplex, qPCR (qPCR)
[13], FISH [14] and blood culture using the BacT/
ALERT 3D system (bioMérieux).
Results
Analysis of patients’ blood samples using methods:
nested, multiplex, qPCR (qPCR), FISH, SeptiFast (SF)
(Roche), and microbiological blood culture
71 blood samples taken from patients with clinical symp-
toms of sepsis were tested by applying the developed
methods (qPCR and FISH) and a commercial SF kit and
with the use of BacT/ALERT® 3D blood culture (bio-
Mérieux). The application of qPCR enabled to increase
the percentage of positive results to 71.8% in comparison
with 36.6% in the case of culture. A lower percentage of
positive results was also recorded for SF (25.3%) and
FISH (29.6%) compared with the one obtained using
qPCR (Table 1).
The developed qPCR method enabled to corroborate
the results obtained with the use of the SF kit in all cases
in which bacteria were detected with simultaneous con-
firmation of Gram-typing. Two results for fungi were
not supported (C. albicans and A. fumigatus).
Neither qPCR nor SF confirmed positive results of
blood culture in the same 6 samples (Table 1). All results
gathered with the use of FISH (Figure 1) were confirmed
by qPCR (Table 1).It was demonstrated that qPCR shows the presence of
microorganisms in blood significantly more frequently
that culturing, FISH, or SF (p < 0.0001; Q = 52.15385). No
significant differences between the remaining methods
were determined.
In all 71 samples, amplification signal was obtained for
the beta-actin gene, confirming that there was no inhib-
ition of the amplification reaction. The applied negative
controls in the form of DNA from sterile blood did not
give an amplification signal.
Discussion
An alternative to the classic diagnosis of sepsis by means
of blood cultures is necessary. From the point of view of
a physician and the quality of care of the patient with a
blood infection, it is essential to get a microbiological
confirmation of sepsis as quickly as possible. Unfor-
tunately, blood cultures frequently require as long as
several days of waiting for the results, and the outcome
is often a false negative [15]. The methods developed
by our team: nested, multiplex, qPCR [13] and FISH
[14] were used to attempt to diagnose sepsis in blood
samples of adult patients with its clinical symptoms
and compared with the effectiveness of the commercial
SeptiFast kit (Roche) and the BacT/ALERT 3D blood
culture system (bioMérieux).
The percentage of positive results obtained using
qPCR amounted to 71.8%, while the other methods, i.e.
culture, FISH and SF, gave 36.2%, 29.6%, and 25.3%,
respectively, and were significantly lower in compari-
son with qPCR (Table 1). qPCR enabled Gram-typing
of bacteria, however, contrary to SF, did not make it
possible to determine the species.
Such a high result for qPCR may suggest that there
has been contamination, especially since nested amplifi-
cation was employed, however, negative control was
used in every case and it always gave a negative result.
Moreover, we obtained very similar data during the test-
ing of blood samples derived from children, in which
qPCR allowed to achieve a proportion of positive results
amounting to 69.6% [13]. Additionally, used primers
specific to 16S rRNA sequences which could detect most
bacteria species what could be the reason of high per-
centage of positive results. All blood samples came
from patients with clinical symptoms of sepsis, which
may suggest that, in the majority of cases, bacteremia
or fungemia occurred, but it was impossible to detect
them with the use of the remaining methods. The
developed qPCR was based on 16S rDNA and 18S
rDNA sequence-specific primers; hence, it allowed the
identification of most species of bacteria and fungi,
whereas the reference SF method enabled the detection of
only over a dozen selected microbial species [16]. It is
possible that the available methods of microbiological
Table 1 Comparison of the results obtained from blood of patients with clinical symptoms of sepsis by the method of
blood culture, the nested multiplex qPCR, FISH and SeptiFast (Roche) methods and the internal inhibition control for
the β-actin gene
(n = 71) Blood culture Nested multiplex qPCR SeptiFast
(Roche)
FISH βactin
geneGram
positive
Gram
negative
Yeast Filamentous
fungi
1 +
2 +
3 S. warneri +
4 +
5 S. epidermidis + CoNS + +
6 + +
7 S. haemolyticus + + +
8 +
9 S. epidermidis + + CoNS + +
10 +
11 + +
12 + +
13 E. cloacae + E. cloacae/aerogrenes + +
14 P. aeruginosa + + +
15 S. haemolyticus + Staphylococcus. spp + +
16 + +
17 + +
18 S. hominis + + +
19 + +
20 +
21 + E. cloacae/aerogrenes +
22 + +
23 + +
24 + +
25 + E. cloacae/aerogrenes + +
26 +
27 + +
28 S. haemolyticus + CoNS + +
29 +
30 + E. cloacae/aerogrenes +
31 + +
32 + K. pneumoniae/oxytoca +
33 + +
34 E. faecium + + E. faecium + +
35 S. mitis + + Streptococcus. spp + +
36 S. hominis + + +
37 S. haemolyticus +
38 + +
39 P. aeruginosa + P. aeruginosa + +
40 + +
41 + A. fumigatus +
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Table 1 Comparison of the results obtained from blood of patients with clinical symptoms of sepsis by the method of
blood culture, the nested multiplex qPCR, FISH and SeptiFast (Roche) methods and the internal inhibition control for
the β-actin gene (Continued)
42 + +
43 + +
44 S. epidermidis +
45 + +
46 + +
47 C. albicans C. albicans +
48 +
49 + K. pneumoniae/oxytoca +
50 E. cloacae +
51 +
52 +
53 S. hominis + + +
54 + + S. aureus +
55 +
56 + +
57 + + +
58 + + +
59 K. pneumoniae + + +
60 S. epidermidis + + + +
61 + +
62 P. acnes + + +
63 + + E. cloacae/aerogenes + +
64 + + + +
65 P. aeruginosa and
S. hominis
+
66 S. epidermidis + + + +
67 K. pneumoniae + + K. pneumoniae/oxytoca + +
68 S. aureus + + + +
69 S. epidermidis + + + +
70 + + + +
71 + +
positive 26* 24 46 0 0 18* 21* 71
51
% 36.6 33.8 64.8 0 0 25.3 29.6 100
71.8
Sensitivity
[CFU/ml]
1x101 [1] 1.1x101 [13] 1.3x101 [13] 8.5x101 [13] 3.7x101 [13] 3x100 – 3x101 [28] 6x103 [14] -
CoNS – coagulase negative Staphylococcus.
CFU = Colony Forming Unit.
„+” – positive result.
„*” – statistically significant differences in comparison with the nested, multiplex, qPCR (there was no significance between the other methods). Cochran’s Q
test; p < 0.0001.
The bold data - summary of results.
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tests, have limitations that only allow the detection of
the most common, from the epidemiological point ofview, microbial species. In patients recovering from ex-
tensive surgical procedures or not fully immunocompe-
tent, bacterial translocation from the gastrointestinal
Figure 1 Picture from a fluorescence microscope, obtained with the use of FISH: (A) visible K. pneumoniae bacteria (sample no. 67);
(B) visible Streptococcus spp. bacteria (sample no. 35); (C) visible E. cloacae bacteria (sample no. 13). Magnification 1000 x.
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we are not able to confirm using commercially available
diagnostic methods [17,18]. The application of nested
PCR makes it possible to achieve greater sensitivity,
which, in turn, allows considerable increase in the
detection of bacteremia, which was showed by Benítez-
Páez et al. whose proportion of positive results was 62.5%
[19]. According to the researchers, the classic diagnostic
methods enable marking of only several percent of
bacterial species in the course of bacteremia, while the
remaining portion is undetectable [19].
With the use of qPCR, all results obtained through the
SF kit as regards bacteremia were confirmed, however, it
failed for two samples, for which the SF test demon-
strated the presence of C. albicans (also corroborated by
culture) and A. fumigatus. The developed qPCR did not
demonstrate the presence of fungi in any of the studied
samples, which may have been caused by difficulties with
fungal DNA isolation, probably due to their thick cell
wall. On the other hand, fungemia occurs in patients
following cardiac surgery in approx. 1% of cases [20];
hence, the examined group of patients may have been
too small to assess the efficiency of qPCR as regards its
capability to identify fungi in blood. The indication of
the presence of A. fumigatus by the SF assay could have
been due to contamination, since the occurrence of this
species in blood is very rare and correlated mainly withpatients with severe hematologic disorders [21]. Source
of contamination was probably the hospital environ-
ment and the contamination might have occurred at
the stage of a blood sample taking from the patient or
during the investigation of samples in the laboratory.
Until now, the only description of the use of FISH for
detection of bacteremia directly in a blood sample was
the study presented by our team [14]; there are, however,
numerous studies on the use of FISH for detecting bac-
teria in blood samples following culture [9,10,22]. The
agreement between the traditional blood culture method
and the PNA-FISH techniques was approximately 98% in
each study, however, it was possible to detect the presence
of bacteria in the culture which did not accelerate the
process of microbiological diagnostics [9,10,22]. The FISH
method made it possible to detect bacteria in 29.6% of
samples and all the results were confirmed by qPCR. The
SF method did not substantiate the results in 10 cases,
which can be explained by the fact that, using FISH,
EUB338 probe was used, which was specific for most bac-
terial species, while SF identified only over a dozen of
them [16], in contrast to qPCR. FISH is cheaper and easier
than SF, therefore, it is suitable as rapid screening of blood
samples in patients with suspected sepsis.
The sensitivity of methods used to detection of micro-
organisms in the blood, expressed in CFU/ml units was
presented in Table 1. According to Jamal and colleague
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at level 1 × 102 CFU/ml [1] as for Nested, multiplex,
qPCR (Table 1) [13]. On the other hand, blood culture
allowed to detect the presence of microorganisms in
36% of samples compared to 71% in the PCR method.
Those difference probably results from the fact that the
bacteria in the blood were inhibited by the immune sys-
tem or used antibiotics which reduced the chances of
their multiplication in a culture medium. PCR methods
detected their DNA only.
Conclusions
Molecular diagnosis of sepsis is becoming imperative on
account of the fact that microbiological cultures are
insufficient as regards their sensitivity and promptness.
The qPCR and FISH methods, which were described in
this study, may constitute an alternative to blood cul-
tures and to the few commercially available molecular
assays since they allow the detection of the majority of
microbial species and qPCR enables their detection in a
greater number of samples than the SF test. FISH made
it possible to find microbes in a blood sample even
before its culture.
Methods
Blood samples
71 blood samples were taken from patients with clinical
symptoms of sepsis, hospitalized in the John Paul II
Hospital in Krakow at The Ward of Anesthesiology and
Intensive Care. Blood samples were drawn into 4-ml
Vacutainer K3E (BectonDickinson) test tubes. Patients were
enrolled into the study according to the SIRS criteria [23].
Ethics statement and participants
The research was granted approval by the local Bioethics
Committee of the Jagiellonian University (KBET/94/B/
2009). Written informed consent was obtained from par-
ticipants before their enrollment in the study.
Blood culture
The blood culture was carried out in the John Paul II
Hospital in Krakow in the Microbiology Department
using BacT/ALERT® 3D apparatus (bioMérieux).
Nested multiplex qPCR (qPCR) amplification
The method for microbial DNA isolation from blood
Microbial DNA was isolated from 1.5-ml blood samples
according to the method described by Gosiewski et al.
with the employment of a ready-to-use Blood Mini
(A&A Biotechnology) [6].
DNA purity and concentration
The concentration and purity of total DNA isolates in
the samples were measured spectrophotometrically atwavelengths of A260 and A280. It was performed in a
NanoDrop machine (Thermo Scientific).PCR amplification
All the processes of DNA amplification were performed
with the use of the real-time PCR method (qPCR) in a
CFX96 thermal cycler (BioRad) by employing species-
specific primers and TaqMan probes (Genomed) ac-
cording to procedure designed by Gosiewski et al. [13].
Additionally, in every sample of DNA isolated from
blood, β-actin gene detection was performed in order
to check whether rtPCR inhibition takes place; SYBR®-
Green JumpStart Taq ReadyMix (Sigma) was used for
that purpose [24].FISH method
200 μl of blood was prepared according to procedure de-
scribed by Gosiewski and colleagues using ammonium
chloride solution (ICN Biomedicals), as in the case of
preparing blood samples for DNA isolation, until a pale
pink pellet was obtained [6]. The pellet was suspended
in 20 μl of sterile deionized water from which 10 μl was
transferred onto SuperFrost®Plus (Menzel–Glaser) micro-
scope slide. The preparation was fixed with 500 μl of 4%
paraformaldehyde (Sigma) solution for 20 min at 4°C.
Then, the preparation was washed with PBS and poured
over with 2 ml of 96% methanol (POCh) for 15 min
at −20°C. Further, methanol was washed off with warm
(37°C) PBS solution and placed on 20 μl of diluted solu-
tion of lysozyme (1 mg/ml) (Sigma) and lysostaphin
(0.05 mg/ml) (Sigma) for 5 min at 37°C. Hybridization
was performed with the use of probes (Genomed) labeled
with fluorochromes at 5′ ends, targeted at the 16S rRNA:
Staphylococcus STA probe was used (CY3-5′ – TCC TCC
ATA TCT CTG CGC 3′) [25]; Enterobacteriaceae,
ENT183 probe (CY3-5′ – CTC TTT GGT CTT GCG
ACG- 3′) [26]; for all bacteria, EUB338 probe was used
(FITC-5′ – GCT GCC TCC CGT AGG AGT - 3′-FITC)
[27]. 5 μl of EUB338 and STA or ENT183 probes solution
(50 ng/μl) was mixed with 40 μl of hybridization buffer:
20 mM Tris HCl pH 7.2 (Sigma); 0.9 M NaCl (Serva);
0,1% SDS (Serva) heated to 50°C. The resulting solu-
tion was transferred onto the preparation and placed
at 50°C in a humid chamber for 2 h. Afterwards, the
probe was washed off with warm hybridization buffer,
except SDS and the preparation was stained with DAPI
(4′,6-diamidino-2-phenylindole) (Sigma) 15 μg/ml for
3 min. The stained preparation was thoroughly washed
with sterile distilled water and dried in the dark. The
specimen was viewed using BX51 fluorescence micro-
scope (Olympus) and F-View camera (Olympus). The
resulting image was analyzed using AnalySYS (Soft
Imaging) software.
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DNA isolation, PCR amplification, and analysis of the
resulting data were conducted in the Department of
Microbiology of the University Hospital in Kraków,
according to the protocol supplied by the manufacturer
and with the use of Roche software.
Statistics
The discrepancies between the methods as regards their
ability to detect microorganisms was studied using
Cochran’s Q test (Gretl software ver. 1.9.4.). P value
of <0.05 was taken as statistically significant.
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